Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2076-2087
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2076
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2076
Figure 1 Treatment strategy for intermediate stage hepatocellular carcinoma.
HCC: Epatocellular carcinoma; MWA: Microwave ablation; ORR: Objective response rate; PFS: Progression-free survival; RFA: Radiofrequency ablation; TACE: Transcatheter arterial chemoembolization.
- Citation: Sho T, Morikawa K, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Shigesawa T, Kimura M, Nakai M, Suda G, Natsuizaka M, Ogawa K, Sakamoto N. Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy. World J Gastrointest Oncol 2021; 13(12): 2076-2087
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2076.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2076